FDA’s draft guidance for AI-enabled medical devices reflects a major change in how regulators address software that changes over time, recognizing AI’s ability to evolve while emphasizing patient safety, transparency and accountability, said Phil Englert of the Health-ISAC.
First seen on govinfosecurity.com
Jump to article: www.govinfosecurity.com/interviews/how-fdas-draft-guidance-shapes-ai-medical-device-safety-i-5550
